News
Cyclomics Secures New Investment to Accelerate Commercialization of Ultra-Sensitive Cancer Diagnostics by Fast and High-Resolution DNA Sequencing Strategie
Cyclomics BV, a pioneer in liquid biopsy technology, announces the successful closing of a new investment round led by Myosotis Investments and supported by Oncode Bridge Fund. ThisLevels Diagnostics advances biomarker validation for early liver cancer detection | Alumni news
Levels Diagnostics, alumnus of the Venture Challenge Fall 2019, has secured new funding to support the clinical validation of its biomarkers for the early detection of liver cancer.
Venture Challenge Winter 2024/25 winner Lumeniris secures EUR 350,000 from Innovatiefonds Noord-Holland | Alumni news
Lumeniris secures funding from Innovatiefonds Noord-Holland to develop pill sized camera for early detection of oesophageal cancer